MedTrace Logo

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

NCT05205343 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-02-04

No results posted yet for this study

Summary

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Conditions

Interventions

OTHER

Standard of Care

complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

OTHER

Control Group

complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Naruhiko Ikoma, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-11
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States
  • Japan
  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205343 on ClinicalTrials.gov